Skip to main content
T

TrialCraft

This startup provides AI-driven software that automates the creation and structuring of clinical research documentation, such as protocols and clinical study reports. Their platform uses smart templates and guided writing to ensure regulatory compliance and enhance productivity for clinical trial teams.

Brussels, Belgium250+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Clinical research documentation, such as protocols and clinical study reports, is a time-consuming process that requires adherence to regulatory standards. The manual creation and structuring of these documents can lead to inconsistencies, errors, and delays in the clinical trial process.

Solution

TrialCraft offers an AI-powered platform designed to automate and streamline the creation of clinical research documentation. The platform leverages intelligent drafting and real-time insights to assist medical writers and regulatory teams in producing high-quality, compliant documents. By using AI to extract relevant data and suggest improvements, TrialCraft reduces redundancy, ensures consistency, and accelerates timelines. The platform also facilitates seamless collaboration across teams with structured authoring tools and access controls, enabling efficient workflows and alignment.

Target Audience

TrialCraft is designed for medical writers, regulatory teams, and team leaders in the pharmaceutical, biotechnology, and medical device industries involved in clinical research and regulatory submissions.

Features

  • AI-powered tools for intelligent retrieval and drafting of clinical documents
  • Real-time insights to ensure compliance with global standards and suggest improvements
  • Structured authoring tools to facilitate alignment across teams
  • Automated first draft generation based on user inputs and existing documents
  • Document structuring with industry regulatory-compliant templates
  • Access controls for managing contributor rights and overall progress visibility
This profile is AI-generated and may contain inaccuracies.